Dr. John B. Liao, MD | Seattle, WA ...

Dr. John B. Liao

Claim this profile

Fred Hutch/University of Washington Cancer Consortium

Studies Ovarian Cancer
Studies Relapse
6 reported clinical trials
9 drugs studied

Area of expertise

1Ovarian Cancer
John B. Liao has run 6 trials for Ovarian Cancer. Some of their research focus areas include:
Stage III
Stage IV
AKT positive
2Relapse
John B. Liao has run 3 trials for Relapse. Some of their research focus areas include:
BRCA positive
Stage IV

Affiliated Hospitals

Image of trial facility.
Fred Hutch/University Of Washington Cancer Consortium
Image of trial facility.
University Of Washington/Seattle Cancer Care Alliance

Clinical Trials John B. Liao is currently running

Image of trial facility.

Pembrolizumab + Carboplatin

for Recurrent Gynecologic Cancer

This phase II trial investigates how well pembrolizumab and carboplatin work in treating patients with ovarian, fallopian tube, or primary peritoneal cancer that has come back (recurrent). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab together with carboplatin may work better in treating patients with recurrent ovarian, fallopian tube, or primary peritoneal cancer.
Recruiting1 award Phase 2

More about John B. Liao

Clinical Trial Related5 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments John B. Liao has experience with
  • Carboplatin
  • Pembrolizumab
  • Afuresertib
  • Paclitaxel
  • AMXT1501
  • DFMO
Breakdown of trials John B. Liao has run
Ovarian Cancer
Relapse
Skin Cancer
Peritoneal Carcinoma
Stomach Cancer

Other Doctors you might be interested in

Stephen SmithFred Hutch/University of Washington Cancer Consortium
Suman JayadevUniversity of Washington
Michael J Wagner, MDFred Hutchinson Cancer Research Center

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John B. Liao specialize in?
John B. Liao focuses on Ovarian Cancer and Relapse. In particular, much of their work with Ovarian Cancer has involved Stage III patients, or patients who are Stage IV.
Is John B. Liao currently recruiting for clinical trials?
Yes, John B. Liao is currently recruiting for 1 clinical trial in Seattle Washington. If you're interested in participating, you should apply.
Are there any treatments that John B. Liao has studied deeply?
Yes, John B. Liao has studied treatments such as Carboplatin, Pembrolizumab, Afuresertib.
What is the best way to schedule an appointment with John B. Liao?
Apply for one of the trials that John B. Liao is conducting.
What is the office address of John B. Liao?
The office of John B. Liao is located at: Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington 98109 United States. This is the address for their practice at the Fred Hutch/University of Washington Cancer Consortium.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top